Preconditioning: a paradigm shift in the biology of myocardial ischemia

被引：168

作者：

Bolli, Roberto ^{[1
]}

机构：

[1] Univ Louisville, Div Cardiol, Inst Mol Cardiol, Louisville, KY 40292 USA

来源：

AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY | 2007年 / 292卷 / 01期

关键词：

nitric oxide synthase; protection; cyclooxygenase-2; NITRIC-OXIDE SYNTHASE; LONG-TERM PROTECTION; LATE-PHASE; GENE-THERAPY; CONSCIOUS RABBITS; UP-REGULATION; INFARCT SIZE; HEART; HYPERCHOLESTEROLEMIA; COX-2;

D O I：

10.1152/ajpheart.00712.2006

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

The discovery of preconditioning (PC) has arguably been the single most important development in the field of ischemic biology in the past 20 years. The significance of this phenomenon transcends cardiovascular medicine, since it is ubiquitously observed in virtually every tissue of the body. This article reviews the pathophysiology and molecular basis of myocardial PC, with particular emphasis on the late phase of this cardioprotective adaptation. The article also discusses the exploitation of late PC for the development of novel gene therapy strategies aimed at inducing a permanently preconditioned cardiac phenotype (prophylactic cardioprotection). Besides its conceptual interest, deciphering the mechanism of late PC has considerable therapeutic reverberations, since transfer of the genes that underlie late PC would be expected to emulate the salubrious effects of this response of the heart to stress.

引用

页码：H19 / H27

页数：9

共 39 条

[1] Preconditioning does not prevent postischemic dysfunction in aging heart [J].

Abete, P ;

Ferrara, N ;

Cioppa, A ;

Ferrara, P ;

Bianco, S ;

Calabrese, C ;

Cacciatore, F ;

Longobardi, G ;

Rengo, F .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1996, 27 (07) :1777-1786

[2] STRUCTURE OF THE HUMAN CYCLO-OXYGENASE-2 GENE [J].

APPLEBY, SB ;

RISTIMAKI, A ;

NEILSON, K ;

NARKO, K ;

HLA, T .

BIOCHEMICAL JOURNAL, 1994, 302 :723-727

[3] Myocardial protection at a crossroads - The need for translation into clinical therapy [J].

Bolli, R ;

Becker, L ;

Gross, G ;

Mentzer, R ;

Balshaw, D ;

Lathrop, DA .

CIRCULATION RESEARCH, 2004, 95 (02) :125-134

[4] The late phase of preconditioning [J].

Bolli, R .

CIRCULATION RESEARCH, 2000, 87 (11) :972-983

[5] The nitric oxide hypothesis of late preconditioning [J].

Bolli, R ;

Dawn, B ;

Tang, XL ;

Qiu, Y ;

Ping, P ;

Xuan, YT ;

Jones, WK ;

Takano, H ;

Guo, Y ;

Zhang, J .

BASIC RESEARCH IN CARDIOLOGY, 1998, 93 (05) :325-338

[6] Cardioprotective function of inducible nitric oxide synthase and role of nitric oxide in myocardial ischemia and preconditioning: an overview of a decade of research [J].

Bolli, R .

JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2001, 33 (11) :1897-1918

[7] Discovery of a new function of cyclooxygenase (COX)-2: COX-2 is a cardioprotective protein that alleviates ischemia/reperfusion injury and mediates the late phase of preconditioning [J].

Bolli, R ;

Shinmura, K ;

Tang, XL ;

Kodani, E ;

Xuan, YT ;

Guo, YR ;

Dawn, B .

CARDIOVASCULAR RESEARCH, 2002, 55 (03) :506-519

[8]

Bolli R, 1997, CIRC RES, V81, P1094

[9] Cardiac-specific abrogation of NF-κB activation in mice by transdominant expression of a mutant IκBα [J].

Dawn, B ;

Xuan, YT ;

Marian, M ;

Flaherty, MP ;

Murphree, SS ;

Smith, TL ;

Bolli, R ;

Jones, WK .

JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2001, 33 (01) :161-173

[10] Ischemic preconditioning protection against stunning in conscious diabetic sheep: role of glucose, insulin, sarcolemmal and mitochondrial KATP channels [J].

del Valle, HF ;

Lascano, EC ;

Negroni, JA .

CARDIOVASCULAR RESEARCH, 2002, 55 (03) :642-659

← 1 2 3 4 →